Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02132247 · ClinicalTrials.gov registry record · Phase 4
Safety Study of Flector Patch in Children With Minor Soft Tissue Injuries
A Phase 4 study of Athletic Injuries, sponsored by IBSA Institut Biochimique.
- Completed
- Registry status
- Phase 4
- Development phase
- 104
- Enrollment target
- 10
- Study locations
NCT02132247 is a Phase 4 study of Athletic Injuries that has completed, run by IBSA Institut Biochimique. The registered enrollment target is 104 participants, below the 188-participant average among 3 other Athletic Injuries trials with a reported enrollment target (45% lower). The trial reports 10 study locations across 6 states.
The verdict
NCT02132247, a Phase 4 study of Athletic Injuries, has completed, sponsored by IBSA Institut Biochimique.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 104 participants
- Enrollment target
- 10
- Study locations
Study Summary
The primary purpose of this study is to determine whether Flector Patch is safe for use in children. The secondary purpose is to assess blood levels of diclofenac, the active ingredient in Flector Patch.
Conditions Studied
Interventions
- DRUG Diclofenac hydroxyethylpyrrolidine
Study Locations (10)
Utah
- Utah Valley Pediatrics - Orem
- J. Lewis Research Inc./Foothill Family Clininc - Salt Lake City
- J. Lewis Research Inc./FirstMed East - Salt Lake City
- J. Lewis Research Inc./Foothill Family Clinic South - Salt Lake City
- Legacy Point Family Medicine - West Point
Arkansas
- Applied Research Center of Arkansas - Little Rock
Florida
- SCORE Physician Alliance - St. Petersburg
Georgia
- Pediatrics and Adolescent Medicine P.A. - Marietta
Texas
- Arlington Family Research Center Inc. - Arlington
Virginia
- Pediatric Research of Charlottesville - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2014-05 |
| Est. Completion | 2017-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02132247
The ClinicalTrials.gov registry entry for NCT02132247 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 188-participant average among 3 other Athletic Injuries trials with a reported enrollment target (45% lower). The listed sponsor is IBSA Institut Biochimique, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Athletic Injuries appearing as the primary indexed condition, and to 1 intervention - of which Diclofenac hydroxyethylpyrrolidine is the first listed.
NCT02132247 reports 10 study locations spanning 6 distinct geographic areas - top geographies include Utah, Arkansas, Florida.
Frequently Asked Questions
What is clinical trial NCT02132247 about?
NCT02132247 is a clinical study titled "Safety Study of Flector Patch in Children With Minor Soft Tissue Injuries". The primary purpose of this study is to determine whether Flector Patch is safe for use in children. The secondary purpose is to assess blood levels of diclofenac, the active ingredient in Flector Patch.
What is the current status of trial NCT02132247?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 104 participants. The study started on 2014-05. Estimated completion is 2017-05.
What conditions does trial NCT02132247 study?
This clinical trial studies the following conditions: Athletic Injuries.
What interventions are being tested in trial NCT02132247?
The interventions under investigation include: Diclofenac hydroxyethylpyrrolidine (DRUG).
Who is sponsoring clinical trial NCT02132247?
This trial is sponsored by IBSA Institut Biochimique, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02132247 being conducted?
This trial has 10 study locations across Arkansas, Florida, Georgia, Texas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Athletic Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.